Precision medicine for gestational diabetes management

FHS
October 9, 2023
10:30 am

Precision markers to predict effective lifestyle and pharmacological interventions to manage Gestational Diabetes Mellitus.

Melinta secures $142M BARDA deal to target pediatric and ‘biothreat’ indications for antibiotics

Melinta Therapeutics secured a BARDA deal worth nearly $142 million to make two currently approved antibiotics available for children. The deal comes roughly three years

July 11, 2023

Restricted Leg Movement in a Tween Boy Reveals an Insidious Skin Disorder

Why did this 11-year-old boy begin to experience increasingly limited range of motion in his right leg, years after developing progressive skin problems on the

February 6, 2024

AI Integration in the Fight Against Age-Related Macular Degeneration

In this interview, Wen Hwa Lee, CEO, and Chief Scientist at Action Against Age-Related Macular Degeneration (AAAMD), offers an enlightening perspective on merging AI with

January 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.